Expression of CD7, CD20 and CDX-2 in a secondary signet-ring cell tumor of the prostate: a case report

Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):269-72. doi: 10.1177/039463201302600130.

Abstract

As is well-known, signet ring cell carcinoma (SRCC) rarely appears as a histological finding in the prostatic tissue. Nevertheless, a differentiation should be made between a primary tumor and a metastatic disease. We describe the case of a 52-year-old man with lower urinary tract symptoms, serum total PSA of 0.2 ng/ml, elevated serum CEA and CA19-9 levels. Two years prior to presentation, he underwent total gastrectomy with histological findings indicating poor differentiated adenocarcinoma with signet-ring cell. A palpable nodule was found on digital rectal examination and for this reason he underwent 12-core transperineal prostate biopsy with a diagnosis of poor differentiated adenocarcinoma with signet-ring cell and adipose tissue infiltration. Immunohistochemical examinations revealed positivity for PAS, CK7 and CDX-2, focal positivity for CK20 and negativity for PSA and PSAP. The diagnosis of a prostatic secondary SRCC was possible given the positivity to CK7, CDX-2, focal positivity to CK20 and negativity to PSA.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antigens, CD20 / metabolism*
  • Antigens, CD7 / metabolism*
  • CDX2 Transcription Factor
  • Carcinoma, Signet Ring Cell / metabolism*
  • Carcinoma, Signet Ring Cell / secondary
  • Homeodomain Proteins / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / secondary
  • Stomach Neoplasms / pathology
  • Trans-Activators / metabolism*

Substances

  • Antigens, CD20
  • Antigens, CD7
  • CDX2 Transcription Factor
  • Homeodomain Proteins
  • Trans-Activators